A 5-year prospective observational study was conducted from 2018 to 2022, including children up to 18 hospitalized with IPD at three major children's hospitals in Catalonia.
Latest Information Update: 26 May 2025
At a glance
- Drugs PCV 15 Tergene Biotech (Primary) ; Pneumococcal 20-valent conjugate vaccine (Primary)
- Indications Pneumococcal infections
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 26 May 2025 New trial record
- 02 May 2025 Results published in the European Journal of Pediatrics